{"effective_time":"20250729","id":"a46df8e4-e921-42f6-8c0b-ced3219fa398","openfda":{},"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL - 50 mg Capsule Blister Pack EXP Lot BRAFTOVI ® 50 mg capsules encorafenib Pierre Fabre Médicament XXXXX PRINCIPAL DISPLAY PANEL - 50 mg Capsule Blister Pack","PRINCIPAL DISPLAY PANEL - 50 mg Capsule Blister Pack Carton BRAFTOVI ® 50 mg hard capsules encorafenib Oral use 28 | hard capsules Pierre Fabre Médicament PRINCIPAL DISPLAY PANEL - 50 mg Capsule Blister Pack Carton"],"set_id":"40e2f621-90c3-4f06-9757-683f9a6b639e","spl_product_data_elements":["BRAFTOVI Encorafenib ENCORAFENIB ENCORAFENIB COPOVIDONE K25-31 POLOXAMER 188 MICROCRYSTALLINE CELLULOSE SUCCINIC ACID CROSPOVIDONE, UNSPECIFIED SILICON DIOXIDE MAGNESIUM STEARATE GELATIN, UNSPECIFIED TITANIUM DIOXIDE FERRIC OXIDE RED FERRIC OXIDE YELLOW FERROSOFERRIC OXIDE SHELLAC PROPYLENE GLYCOL Swedish Biege A;LGX;50mg"],"version":"3"}